Curocell Inc

NEW
XKRX:372320 (Korea (the Republic of))  
â‚© 29700.00 (-1.33%) Oct 31
At Loss
P/B:
8.77
Market Cap:
â‚© 418.48B ($ 304.39M)
Enterprise V:
â‚© 428.24B ($ 311.49M)
Volume:
37.13K
Avg Vol (2M):
107.45K
Trade In:
Volume:
37.13K
At Loss
Avg Vol (2M):
107.45K
PE Ratio PS Ratio PB Ratio Price-to-FCF Market Cap
Current and historical daily PE Ratio for Curocell Inc ( ) from 2023 to Oct 31 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Curocell stock (XKRX:372320) PE ratio as of Oct 31 2024 is 0. More Details

Curocell Inc (XKRX:372320) PE Ratio (TTM) Chart

To

Curocell Inc (XKRX:372320) PE Ratio (TTM) Historical Data

Total 237
  • 1
  • 2
  • 3
Curocell PE Ratio (TTM) Historical Data
Date PE Ratio (TTM) Data Date PE Ratio (TTM) Data
2024-10-31 At Loss 2024-08-21 At Loss
2024-10-31 At Loss 2024-08-20 At Loss
2024-10-30 At Loss 2024-08-19 At Loss
2024-10-29 At Loss 2024-08-16 At Loss
2024-10-28 At Loss 2024-08-14 At Loss
2024-10-25 At Loss 2024-08-13 At Loss
2024-10-24 At Loss 2024-08-12 At Loss
2024-10-23 At Loss 2024-08-09 At Loss
2024-10-22 At Loss 2024-08-08 At Loss
2024-10-21 At Loss 2024-08-07 At Loss
2024-10-18 At Loss 2024-08-06 At Loss
2024-10-16 At Loss 2024-08-05 At Loss
2024-10-15 At Loss 2024-08-02 At Loss
2024-10-14 At Loss 2024-08-01 At Loss
2024-10-11 At Loss 2024-07-31 At Loss
2024-10-10 At Loss 2024-07-30 At Loss
2024-10-08 At Loss 2024-07-29 At Loss
2024-10-07 At Loss 2024-07-26 At Loss
2024-10-04 At Loss 2024-07-25 At Loss
2024-10-02 At Loss 2024-07-24 At Loss
2024-09-30 At Loss 2024-07-23 At Loss
2024-09-27 At Loss 2024-07-22 At Loss
2024-09-26 At Loss 2024-07-19 At Loss
2024-09-25 At Loss 2024-07-18 At Loss
2024-09-24 At Loss 2024-07-17 At Loss
2024-09-23 At Loss 2024-07-16 At Loss
2024-09-20 At Loss 2024-07-15 At Loss
2024-09-19 At Loss 2024-07-12 At Loss
2024-09-13 At Loss 2024-07-11 At Loss
2024-09-12 At Loss 2024-07-10 At Loss
2024-09-11 At Loss 2024-07-09 At Loss
2024-09-10 At Loss 2024-07-08 At Loss
2024-09-09 At Loss 2024-07-05 At Loss
2024-09-06 At Loss 2024-07-04 At Loss
2024-09-05 At Loss 2024-07-03 At Loss
2024-09-04 At Loss 2024-07-02 At Loss
2024-09-03 At Loss 2024-07-01 At Loss
2024-09-02 At Loss 2024-06-28 At Loss
2024-08-30 At Loss 2024-06-27 At Loss
2024-08-29 At Loss 2024-06-26 At Loss
2024-08-28 At Loss 2024-06-25 At Loss
2024-08-27 At Loss 2024-06-24 At Loss
2024-08-26 At Loss 2024-06-21 At Loss
2024-08-23 At Loss 2024-06-20 At Loss
2024-08-22 At Loss 2024-06-19 At Loss

Curocell Inc (XKRX:372320) PE Ratio (TTM) Comparison

Company Market Cap(Mil) PE Ratio (TTM)

Business Description

Business Description

Compare
Compare
Traded in other countries / regions
372320.Korea
IPO Date
2023-11-09
Description
Curocell Inc is engaged in medical and pharmaceutical research and development. The company is into development of CAR-T treatments that enhance the natural function of immune cells to eliminate cancer cells through genetic manipulation of human immune cells.